11/06/2021 Petri Lampinen, member of the European Working Group of People with Dementia, manages to overcome the limitations imposed by COVID Living with dementia
08/06/2021 Alzheimer Europe contributes to paper on “Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care” Alzheimer Europe
08/06/2021 Anavex completes enrolment of its Phase II/III clinical trial in people with Alzheimer’s disease Science watch
07/06/2021 FDA approves aducanumab, a first disease-modifying treatment for Alzheimer's disease Science watch
01/06/2021 The AMYPAD Prognostic and Natural History Study reaches milestone of 1.000 research participants EU projects
01/06/2021 Researchers identify changes in novel plasma proteins that may signal increased dementia risk many years before disease onset Science watch
01/06/2021 EU Commission launches public consultation on the European Health Data Space EU developments
31/05/2021 One month left to submit your abstracts for the virtual 31st Alzheimer Europe Conference Alzheimer Europe
